KINGSTREE, S.C. — One morning in late April, a small brick health clinic along the Thurgood Marshall Highway bustled with patients. There was Joshua McCray, 69, a public bus driver who, four years after catching covid-19, still is too weak to drive. Louvenia McKinney, 77, arrived complaining about shortness of breath. Ponzella McClary brought her…
By NAHEEM NOAH A Call from the Black Hole Three months into building Carenector’s facility-to-facility platform, I got a call that crystallized everything wrong with healthcare referrals. A hospital social worker, who was already using our individual patient platform to help families find care, had been trying to coordinate an institutional placement for an 82-year-old…
PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the AMA last year accusing it of “abus[ing] [its] government-backed monopoly by charging exorbitant fees to anyone…
Trump drug price ultimatum.Baumol cost disease: Child care vs. pet care & health care vs. veterinary care editions.Jennifer Doudna interview on CRISPR.AMA on PBMs.Life 30,000 feet underwater.
Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ready for pivotal testing. BlossomHill Therapeutics also debuted on the Nasdaq, raising cash for cancer drugs designed to address mutations not covered by currently available therapies. The post Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain…
[Sponsored] A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access. The post How Can RWD Transform the Patient Journey? appeared first on MedCity News.
KFF Standards and Practices Published: January 13, 2025 Introduction This document’s intent is to serve as a roadmap that sets expectations clearly for how we work together and behave in a principled and ethical manner. It applies equally to all KFF staff across the board as well as for any freelancers doing work under our…More
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.
Natalie Schneider is CEO of Fort Health, a relatively new entrant into the children’s mental health market. Fort Health’s modus operandi is to partner with (i.e. market via) pediatricians to recruit patients. They are delivering integrated care and something called collaborative care…a newer model that has more frequent and shorter interventions and is more affordable….